Related Experiment Videos
Assembly of fibronectin into extracellular matrix
D F Mosher1, F J Fogerty, M A Chernousov
1Department of Medicine, University of Wisconsin, Madison 53706.
Annals of the New York Academy of Sciences
|January 1, 1991
Summary
Fibronectin assembly is a key biological process influencing cell interactions and matrix deposition. Understanding this process may reveal new treatments for diseases involving tissue damage and fibrosis.
Area of Science:
- Cell biology
- Biochemistry
- Extracellular matrix research
Background:
- Fibronectin matrix assembly is a fundamental biological process.
- Cellular interactions with extracellular molecules are crucial in physiological and pathophysiological states.
- Fibronectin deposition is tightly regulated, similar to its synthesis and receptor expression.
Purpose of the Study:
- To elucidate the fundamental process of fibronectin assembly.
- To explore how fibronectin assembly influences cell-extracellular molecule interactions.
- To present testable models for fibronectin assembly to advance understanding and therapeutic strategies.
Main Methods:
- The study likely involved in vitro or in vivo models to observe fibronectin deposition.
- Analysis of cellular and molecular factors influencing fibronectin matrix formation.
- Investigated the roles of transforming growth factor-beta (TGF-beta) and factor XIII in fibronectin assembly.
Main Results:
- Fibronectin assembly is a critical process with implications for cell communication.
- Matrix deposition is regulated by cellular synthesis, adhesion receptors, and coagulation factors like TGF-beta and factor XIII.
- Cellular interactions, such as stromal cells influencing lymphocytes via fibronectin, are mediated by this assembly process.
Conclusions:
- Knowledge of fibronectin assembly offers insights into cell-extracellular matrix interactions.
- Fibronectin assembly plays a role in physiological and pathophysiological processes, including fibrosis and tissue repair.
- Understanding fibronectin assembly may lead to novel therapeutic approaches for fibrotic diseases, tissue damage, and cancer.